The BEST-CLI trial: A multidisciplinary effort to assess which therapy is best for patients with critical limb ischemia

Techniques in Vascular and Interventional Radiology

Volumn 17, Issue 3, 2014, Pages 221-224

  Farber, Alik ^a   Rosenfield, Kenneth ^b   Menard, Matthew ^c  

^a BOSTON MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Controlled randomized trial; Critical limb ischemia; Endovascular therapy; Surgical bypass

Indexed keywords

ANGIOPLASTY; ARTICLE; BLOOD VESSEL SHUNT; BYPASS SURGERY; CARDIOLOGIST; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; CRITICAL LIMB ISCHEMIA; ENDOVASCULAR SURGERY; EQUIPOISE; HEALTH CARE COST; HUMAN; INTENTION TO TREAT ANALYSIS; INTERVENTIONAL RADIOLOGIST; LIMB AMPUTATION; LIMB SALVAGE; OPEN STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERSONALIZED MEDICINE; QUALITY OF LIFE; REVASCULARIZATION; SURGICAL PATIENT; VASCULAR SURGEON; CLINICAL TRIAL (TOPIC); ISCHEMIA; LIMB; PATIENT CARE; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; PROCEDURES; RADIOGRAPHY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VASCULARIZATION;

CLINICAL TRIALS AS TOPIC; EXTREMITIES; HUMANS; ISCHEMIA; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT CARE TEAM; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84927669281     PISSN: 10892516     EISSN: 15579808     Source Type: Journal    
DOI: 10.1053/j.tvir.2014.08.012     Document Type: Article

References (29)

1. Norgren L., et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007, 45(suppl S):S5-67.
2. Selvin E., Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the national health and nutrition examination survey, 1999-2000. Circulation 2004, 110(6):738-743.
3. Hunink M.G., et al. Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. J Am Med Assoc 1995, 274(2):165-171.
4. Singh S., et al. The costs of managing lower limb-threatening ischaemia. Eur J Vasc Endovasc Surg 1996, 12(3):359-362.
5. Shah D.M., et al. Long-term results of in situ saphenous vein bypass. Analysis of 2058 cases. Ann Surg 1995, 222(4):438-446. [discussion 446-8].
6. Schanzer A., et al. Technical factors affecting autogenous vein graft failure: Observations from a large multicenter trial. J Vasc Surg 2007, 46(6):1180-1190. [discussion 1190].
7. Veith F.J., et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986, 3(1):104-114.
8. Conte M.S., et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg 2009, 50(6):1462-1473. (e1-3).
9. Isner J.M., Rosenfield K. Redefining the treatment of peripheral artery disease. Role of percutaneous revascularization. Circulation 1993, 88(4 Pt 1):1534-1557.
10. Anderson P.L., et al. Understanding trends in inpatient surgical volume: Vascular interventions, 1980-2000. J Vasc Surg 2004, 39(6):1200-1208.
11. Goodney P.P., et al. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg 2009, 50(1):54-60.
12. Rocha-Singh K.J., et al. Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: The XCELL trial. Catheter Cardiovasc Interv 2012, 80(6):1042-1051.
13. Bosiers M., et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg 2012, 55(2):390-398.
14. Conte M.S. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia. J Vasc Surg 2010, 51(suppl 5):69S-75S.
15. Bradbury A., et al. Bypass versus angioplasty to treat severe limb ischemia: Factors that affect treatment preferences of UK surgeons and interventional radiologists. J Vasc Surg 2004, 39(5):1026-1032.
16. White C.J., Gray W.A. Endovascular therapies for peripheral arterial disease: An evidence-based review. Circulation 2007, 116(19):2203-2215.
17. Goodney P.P., et al. Variation in the use of lower extremity vascular procedures for critical limb ischemia. Circ Cardiovasc Qual Outcomes 2012, 5(1):94-102.
18. Hirsch A.T., et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): Executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006, 47(6):1239-1312.
19. Rooke T.W., et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011, 58(19):2020-2045.
20. Beard J.D. Which is the best revascularization for critical limb ischemia: Endovascular or open surgery?. J Vasc Surg 2008, 48(suppl 6):11S-16S.
21. Meier G.H. Current literature for evidence-based infrainguinal endovascular treatment. Semin Vasc Surg 2008, 21(4):210-216.
22. Adam D.J., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): Multicentre, randomised controlled trial. Lancet 2005, 366(9501):1925-1934.
23. Bradbury A.W., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010, 51(suppl 5):5S-17S.
24. Bradbury A.W. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: What are its implications?. Semin Vasc Surg 2009, 22(4):267-274.
25. Conte M.S., et al. Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 2006, 43(4):742-751. [discussion 751].
26. Mcpherson H. Pragmatic clinical trials. Complement Ther Med 2004, 12(2-3):136-140.
27. Kumar A., et al. FDA perspective on objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg 2009, 50(6):1474-1476.
28. Conway K., Uzun V., Girod I., et al. Linguistic validation of the Vascular Quality of Life Questionnaire (VASCUQOL) in 8 languages. Value Health 2000, 3(2):113.
29. The EuroQol Group EuroQol-A new facility for the measurement of health-related quality of life. Health Policy 1990, 16(3):199-208.